IMPROVING UTILIZATION OF SGLT-2 INHIBITORS IN VETERANS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE IN A VA PRIMARY CARE CLINIC

被引：0
|
作者：
Anderson, Rachel [1 ]
Day, Jonathan [1 ]
de la Serna, Solanus [1 ]
Hines, Mackenzie [1 ]
Prathivadhi-Bhayankaram, Sruti [1 ]
Salomone, Joseph [1 ]
Vather, Naomi [1 ]
Zandvakili, Arya [1 ]
Brettell, Leslie [1 ]
Johnson, Krista M. [2 ]
Hupp, Derek [3 ]
机构：
[1] Univ Iowa Hosp & Clin, Internal Med, Iowa City, IA USA
[2] Univ Iowa, Internal Med, Iowa City, IA USA
[3] Iowa City VA Med Ctr, Internal Med, Iowa City, IA USA
来源：
JOURNAL OF GENERAL INTERNAL MEDICINE | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：S695 / S695
页数：1
相关论文
共 50 条
  • [21] The SGLT-2 Inhibitors in Personalized Therapy of Diabetes Mellitus Patients
    Tilinca, Mariana Cornelia
    Tiuca, Robert Aurelian
    Tilea, Ioan
    Varga, Andreea
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (12):
  • [22] SGLT-2 inhibitors on cardiac autonomic function in individuals with and without type 2 diabetes mellitus
    Ozel, Hasan Fehmi
    Alpay, Suheda
    Asker, Emre
    Gultekin, Elif Sidal
    Kazdagli, Hasan
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2025, 39 (05)
  • [23] BP-lowering effects of SGLT-2 inhibitors and finerenone: an indirect comparison in patients with chronic kidney disease and type 2 diabetes
    Georgianos, Panagiotis I.
    Kourtidou, Christodoula
    Divani, Maria
    Liakopoulos, Vassilios
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (02) : 127 - 130
  • [24] Effect of the SGLT-1 and SGLT-2 Inhibitors Sotagliflozine on the Treatment of Type 1 Diabetes mellitus
    Pavlicek, Vojtech
    DIABETOLOGE, 2019, 15 (06): : 585 - 586
  • [25] SGLT-2 inhibitors in heart failure and chronic kidney disease: A review for internists
    Jaswaney, Rahul
    Sokoloff, Samantha
    Rakita, Val
    Rubin, Daniel J.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2024, 91 (07) : 415 - 423
  • [26] SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes
    David C. Wheeler
    June James
    Dipesh Patel
    Adie Viljoen
    Amar Ali
    Marc Evans
    Kevin Fernando
    Debbie Hicks
    Nicola Milne
    Philip Newland-Jones
    John Wilding
    Diabetes Therapy, 2020, 11 : 2757 - 2774
  • [27] SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes
    Wheeler, David C.
    James, June
    Patel, Dipesh
    Viljoen, Adie
    Ali, Amar
    Evans, Marc
    Fernando, Kevin
    Hicks, Debbie
    Milne, Nicola
    Newland-Jones, Philip
    Wilding, John
    DIABETES THERAPY, 2020, 11 (12) : 2757 - 2774
  • [28] Pharmacokinetics, Pharmacodynamics and Clinical Use of SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
    Scheen, Andre J.
    CLINICAL PHARMACOKINETICS, 2015, 54 (07) : 691 - 708
  • [29] Pharmacokinetics, Pharmacodynamics and Clinical Use of SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
    André J. Scheen
    Clinical Pharmacokinetics, 2015, 54 : 691 - 708
  • [30] Clinical Spectrum and Mechanism of Acute Kidney Injury in Patients with Diabetes Mellitus on SGLT-2 Inhibitors
    Perlman, Amichai
    Heyman, Samuel N.
    Stokar, Joshua
    Darmon, David
    Muszkat, Mordechai
    Szalat, Auryan
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2018, 20 (08): : 513 - 516
12345